# Study on Drug Interactions Affecting the Pharmacokinetics of RSS0343 Tablet

> **NCT07696091** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Reistone Biopharma Company Limited** · enrollment: 40 (estimated)

## Conditions studied

- Non-cystic Fibrosis Bronchiectasis、Chronic Sinusitis Without Nasal Polyps、Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** RSS0343 Tablet; Rifampicin Capsules
- **DRUG:** RSS0343 Tablet; Clarithromycin Tablets

## Key facts

- **NCT ID:** NCT07696091
- **Lead sponsor:** Reistone Biopharma Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07696091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07696091, "Study on Drug Interactions Affecting the Pharmacokinetics of RSS0343 Tablet". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07696091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*